Showing results (271-280 of 386) with videos related to
Sort By:
Pageof 39
Glycoconjugate Journal|February 17, 2017
Clinicopathological significance of ganglioside DSGb5 expression in renal cell carcinomaJun Itoh, Akihiro Ito, Shuichi Shimada, et al.The Journal of Toxicological Sciences|August 7, 2012
Assessment of technical protocols for novel embryonic stem cell tests with molecular markers (Hand1- and Cmya1-ESTs): a preliminary cross-laboratory performance analysisNoriyuki Suzuki, Norihisa Yamashita, Naoteru Koseki, et al.Journal of Neurosurgery|November 10, 2009
Imaging of hypoxic lesions in patients with gliomas by using positron emission tomography with 1-(2-[18F] fluoro-1-[hydroxymethyl]ethoxy)methyl-2-nitroimidazole, a new 18F-labeled 2-nitroimidazole analogIchiyo Shibahara, Toshihiro Kumabe, Masayuki Kanamori, et al.Human Pathology|June 14, 2018
Myosin 5a regulates tumor migration and epithelial-mesenchymal transition in esophageal squamous cell carcinoma: utility as a prognostic factorNaomi Sato, Fumiyoshi Fujishima, Yasuhiro Nakamura, et al.Neuroendocrinology|March 21, 2015
Progesterone Receptor Isoforms A and B in Pancreatic Neuroendocrine TumorSamaneh Yazdani, Atsuko Kasajima, Hiroko Ogata, et al.Cancer Science|April 11, 2017
Cytochrome c1 in ductal carcinoma in situ of breast associated with proliferation and comedo necrosisMayuko Chishiki, Kiyoshi Takagi, Ai Sato, et al.The Journal of Investigative Dermatology|November 7, 2021
Wnt/β-Catenin Signaling Stabilizes Hemidesmosomes in KeratinocytesHideyuki Kosumi, Mika Watanabe, Satoru Shinkuma, et al.Neuro-Oncology|May 10, 2013
The expression status of CD133 is associated with the pattern and timing of primary glioblastoma recurrenceIchiyo Shibahara, Yukihiko Sonoda, Ryuta Saito, et al.Human Pathology|March 25, 2014
Angiogenesis and vascular maturation in neuroendocrine tumorsSamaneh Yazdani, Atsuko Kasajima, Kentaro Tamaki, et al.International Journal of Clinical Oncology|October 6, 2011
IDH1/2 gene status defines the prognosis and molecular profiles in patients with grade III gliomasIchiyo Shibahara, Yukihiko Sonoda, Masayuki Kanamori, et al.Pageof 39